| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TTC7A | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | SH3GL3 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | NOM1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | ZFP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | GAB1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | TBX6 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | CD8A | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | HNRNPDL | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | GRID2IP | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | SLC29A1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
